Helmut Jeggle

Active Investor

Managing Partner at SALVIA GmbH

Munich, Bavaria

Helmut Jeggle, Managing Partner at SALVIA GmbH is an active investor based in Munich, Bavaria. This profile covers what Helmut Jeggle backs, at which stage, and how founders can reach out in 2026.

Mr. Helmut Jeggle serves as a Board Member at Glycotope. He is a Co-Founder and serves as Board Member at Bambusa Therapeutics. He serves as Deputy Chairman at CorTec. He served as Managing Director at Santo Venture Capital. He served as a Board Member at Ganymed Pharmaceuticals and IQM. He is an accomplished senior executive manager with more than 20 years of international experience in the financial field, including strategic management within corporate/non-corporate environments as well as substantial transactional experience. He is currently the Chief Executive Officer of Salvia GmbH (since 2014). Until 2021, he held CEO positions at Neula Holding GmbH and AT-Gruppe and was a manager of Santo Group . He is a member of numerous supervisory boards, including 4SC AG, AiCuris AG, BioNTech SE, and Tonies SE. He holds a degree in business administration from the University of Applied Sciences Neu-Ulm and earned his MBA from the Stuttgart Institute of Management and Technology. He serves as a Board Member at OQmented and November - Vorsorge & Bestattungen. He is the Founder and serves as the Managing Partner at Salvia. He serves as a Board Member at AiCuris. He serves as Managing Director at ATHOS Service. He serves as a Member of the Supervisory Board at BioNTech. He is responsible for the life science initiatives of the StrÃ¼ngmann brothers. Previously, he was the Head of Business Planning & Analyses at Hexal AG and is currently a member of numerous Supervisory Boards. Hexal was sold to Novartis in 2005 for $8.3bn in cash. He has a degree in business administration from the FH Neu-Ulm and earned his MBA from the Stuttgart Institute of Management and Technology (SIMT) during his time at Hexal.

Investor type: AngelVCPE
Stages: Early Stage VentureSeries ASeries B
Invests in: Healthcare & BiotechBiotech & PharmaSaaS & EnterpriseConsumer & RetailClimate & EnergyDeveloper Tools & DataQuantum & SemiconductorsRobotics & Automation
Location: Munich, Bavaria
Typical check: $1M
Past investments: 5

Notable investments

NovemberIQM Quantum ComputersBioNTech SE4SC AGAiCuris Anti-infective Cures AG

How to reach Helmut Jeggle

Angels and operators like Helmut Jeggle reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Helmut Jeggle invest in?

Helmut Jeggle invests in Healthcare & Biotech, Biotech & Pharma, SaaS & Enterprise and Consumer & Retail, typically at Early Stage Venture, Series A and Series B. Match your sector and stage, then reach out with a personalized pitch.